Profile
Paul McInulty is currently the Senior Vice President-Regulatory Affairs at Arvinas, Inc. Prior to this, he worked as the Vice President-Therapeutic Head & Hematology at Bristol Myers Squibb Co. and as the Vice President-Regulatory Affairs at Celgene Corp.
He completed his undergraduate degree at The University of Sheffield.
Paul McInulty active positions
| Companies | Position | Start |
|---|---|---|
| ARVINAS, INC. | General Counsel | 2022-10-02 |
Former positions of Paul McInulty
| Companies | Position | End |
|---|---|---|
| CELGENE | General Counsel | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of Paul McInulty
| The University of Sheffield | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ARVINAS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Paul McInulty
